Haematological cancer: Lenalidomide maintenance-perils of a premature denouement

Nature Reviews Clinical Oncology

Volumn 9, Issue 7, 2012, Pages 372-374

  Rajkumar, S Vincent ^a  

^a Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BORTEZOMIB; LENALIDOMIDE; MELPHALAN; PLACEBO; THALIDOMIDE;

ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER RELAPSE; CANCER RISK; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; DRUG EFFICACY; HUMAN; MULTIPLE MYELOMA; MYELOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; QUALITY OF LIFE; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SURVIVAL RATE; TREATMENT DURATION; TUMOR VOLUME;

ANTINEOPLASTIC AGENTS; DISEASE MANAGEMENT; HEMATOLOGIC DISEASES; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEVERITY OF ILLNESS INDEX; THALIDOMIDE;

EID: 84863482086     PISSN: 17594774     EISSN: 17594782     Source Type: Journal    
DOI: 10.1038/nrclinonc.2012.100     Document Type: Article

References (10)

1. McCarthy, P. L. et al. Lenalidomide after stem-cell transplantation for multiple myeloma. N. Engl. J. Med. 366, 1770-1781 (2012).
2. Attal, M. et al. Lenalidomide maintenance after stem-cell transplantation for multiple myeloma. N. Engl. J. Med. 366, 1782-1791 (2012).
3. Palumbo, A. et al. Continuous lenalidomide treatment for newly diagnosed multiple myeloma. N. Engl. J. Med. 366, 1759-1769 (2012).
4. Rajkumar, S. V. Treatment of multiple myeloma. Nat. Rev. Clin. Oncol. 8, 479-491 (2011).
5. Kumar, S. et al. Trisomies in multiple myeloma: impact on survival in patients with high-risk cytogenetics. Blood 119, 2100-2105 (2012).
6. Russell, S. J. & Rajkumar, S. V. Multiple myeloma and the road to personalised medicine. Lancet Oncol. 12, 617-619 (2011).
7. Attal, M. et al. Maintenance therapy with thalidomide improves survival in patients with multiple myeloma. Blood 108, 3289-3294 (2006).
8. Spencer, A. et al. Consolidation therapy with low-dose thalidomide and prednisolone prolongs the survival of multiple myeloma patients undergoing a single autologous stem-cell transplantation procedure. J. Clin. Oncol. 27, 1788-1793 (2009).
9. Rajkumar, S. V., Gahrton, G. & Bergsagel, P. L. Approach to the treatment of multiple myeloma: a clash of philosophies. Blood 118, 3205-3211 (2011).
10. Badros, A. Z. Lenalidomide in myeloma\a high-maintenance friend. N. Engl. J. Med. 366, 1836-1838 (2012).